Related Experiment Video
Updated: May 9, 2025

08:12
Normothermic Ex Vivo Kidney Perfusion for the Preservation of Kidney Grafts prior to Transplantation
Published on: July 15, 2015
19.0K
Outcomes for Patients With a Deceased Donor Kidney Offer in the New Allocation System
Sumit Mohan1,2,3, Miko Yu1,2, Lindsey M Maclay1,2
1Division of Nephrology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Kidney International Reports
|April 30, 2025
Summary
Kidney allocation policy changes led to more organ offers but also increased declines, highlighting inefficiencies. Rethinking patient prioritization is crucial for maximizing lifesaving organ utilization in end-stage kidney disease patients.
Area of Science:
- Nephrology
- Transplantation Medicine
- Public Health Policy
Background:
- Disparities in kidney transplantation access persist for US patients with end-stage kidney disease.
- Recent kidney allocation policy changes correlate with a significant rise in declined organ offers.
Purpose of the Study:
- To analyze transplant and mortality rates for waitlisted candidates from 2015 to 2022.
- To evaluate the impact of kidney allocation policy changes on organ offer utilization.
Main Methods:
- Retrospective analysis of 249,145 adult waitlisted candidates.
- Examined transplant rates, mortality, and organ offer data from 2015 to 2022.
Main Results:
- The number of organ offers generated increased dramatically, from ~7.9 million in 2015 to ~29.3 million in 2022.
- Despite increased offers, 37.7% received deceased donor kidneys, 14.7% living donor kidneys, while 7.4% died and 12.7% were removed from the list.
- Median days to first offer decreased significantly, but deceased patients received numerous offers before death.
Conclusions:
- Current kidney allocation algorithms demonstrate significant inefficiencies.
- There is a critical need to revise waitlist prioritization strategies to optimize the use of deceased donor organs.
- Improving organ utilization is essential for maximizing the chances of successful kidney transplantation for end-stage kidney disease patients.
Related Concept Videos
Bone Marrow Sampling and Transplants
260
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
260
Tissue Transplantation
271
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
271

